Wednesday, December 14, 2016

BRIEF-Cytori Therapeutics says ADRESU incontinence trial hits 50 pct enrollment milestone

* Cytori pivotal ADRESU incontinence trial hits 50 pct

enrollment milestone

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)